PharmX Technologies Limited (ASX:PHX)
Australia · Delayed Price · Currency is AUD 0.1150
+0.0050 (4.55%)
At close: Aug 28, 2025
PharmX Technologies Market Cap
PharmX Technologies has a market cap or net worth of 68.83 million as of August 29, 2025. Its market cap has increased by 130.00% in one year.
Market Cap
68.83M
Enterprise Value
65.55M
Revenue
7.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since March 16, 1998, PharmX Technologies's market cap has increased from 21.78M to 68.83M, an increase of 215.96%. That is a compound annual growth rate of 4.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 68.83M | 55.41% |
| Dec 31, 2024 | 44.29M | 80.49% |
| Dec 28, 2023 | 24.54M | 32.51% |
| Dec 28, 2022 | 18.52M | -49.95% |
| Dec 31, 2021 | 37.00M | -32.61% |
| Dec 29, 2020 | 54.90M | 68.37% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 103.08B |
| Pro Medicus | 31.23B |
| Cochlear | 19.72B |
| Sonic Healthcare | 11.89B |
| Ramsay Health Care | 7.79B |
| Telix Pharmaceuticals | 4.94B |
| Ansell | 4.91B |
| Mesoblast | 2.79B |